AES to go private in $33.4B buyout by GIP and EQT consortium
AES (NYSEAES) announced Monday that it has entered into a definitive merger agreement to be taken private by a consortium of heavyweight infrastructure investors.
Todas as matérias desta seção, das mais recentes às mais antigas — página 269 de 371.
AES (NYSEAES) announced Monday that it has entered into a definitive merger agreement to be taken private by a consortium of heavyweight infrastructure investors.
Uniti Group (NASDAQ:UNIT) reported a fourth-quarter net loss of $305.7 million on Monday, reflecting the heavy financial lifting required to complete its massive merger with Windstream.
Nvidia (NASDAQ:NVDA) moved to secure the future of AI networking on Monday, announcing twin $2 billion investments in photonic product leaders Lumentum Holdings (NASDAQ:LITE) and Coherent (NYSE:COHR).
Turning Point Brands (NYSE:TPB) delivered a strong conclusion to fiscal 2025, reporting fourth-quarter net income of $8.2 million, or 42 cents per share.
Apogee Therapeutics (NASDAQ:APGE) solidified its clinical roadmap for 2026 on Monday, reporting a year-end cash position of $902.9 million.
WhiteHorse Finance (NASDAQ:WHF) reported fourth-quarter net income of $8.4 million on Monday, delivering a performance that cleared analyst hurdles on both the top and bottom lines.
Xeris Biopharma Holdings (NASDAQ:XERS), a Chicago-based specialty pharmaceutical company focused on therapies for rare endocrine and metabolic diseases, on Monday reported net income of $11.1 million for its fourth quarter ended December 31, 2025.
Kaspi.kz (NASDAQ:KSPI) delivered a robust set of fiscal 2025 results, reporting a 19% year-over-year increase in total revenue to KZT 3.1 trillion.
uniQure (NASDAQ:QURE) entered 2026 with a dual narrative of clinical progress and regulatory complexity.
Compugen (NASDAQ:CGEN) delivered a transformative fiscal 2025, reporting a sharp pivot to profitability and a significantly bolstered balance sheet.
ADT ( NYSE:ADT) delivered a robust fiscal 2025 performance, reporting total revenue of $5.13 billion, a 5% increase over the prior year.
Sealed Air (NYSE:SEE), a leading provider of protective packaging solutions, including Bubble Wrap, Cryovac food packaging, and automated systems, on Monday reported fourth-quarter net sales of $1.40 billion for the period ended December 31, 2025.
Venture Global (NYSE:VG) delivered a blockbuster set of financial results for fiscal 2025, cementing its position as a dominant force in the global energy transition.
Norwegian Cruise Line Holdings (NYSE:NCLH) delivered a robust fiscal 2025 performance, reporting record total revenue of $9.8 billion.
Vision Marine Technologies (NASDAQ:VMAR) disclosed significant growth within its direct-to-consumer rental division on Monday, reporting that its Portside Ventura, California operations saw a 167% year-over-year increase in excursion volume.
EchoStar (NASDAQ:SATS) disclosed a massive $14.50 billion net loss for the full year 2025, a figure primarily fueled by a series of aggressive accounting adjustments to its balance sheet.
Hudbay Minerals (NYSE:HBM) and Arizona Sonoran Copper Company (ASCU) announced a definitive merger agreement on Monday, marking the creation of a massive new "copper district" in southern Arizona.
TRX Gold (NYSE:TRX) delivered a landmark second quarter for fiscal 2026, reporting record production and a transformed capital structure that positions the company for aggressive growth at its Buckreef Gold Project.
Zymeworks (NASDAQ:ZYME) reported a significant narrowing of its annual losses and a double-digit jump in revenue on Monday, driven by the continued maturation of its oncology-focused licensing portfolio.
RadNet (NASDAQ:RDNT) reported record fourth-quarter and full-year 2025 results today, underscoring the success of its dual-track strategy to dominate both physical outpatient imaging and the burgeoning clinical AI market.
Belite Bio (NASDAQ:BLTE), a clinical-stage biopharmaceutical company focused on developing therapies for degenerative retinal diseases, today announced positive topline results from its pivotal Phase 3 DRAGON trial evaluating tinlarebant, an oral retinol binding protein 4 (RBP4) antagonist, for the treatment of adolescent Stargardt disease.
RadNet (NASDAQ:RDNT) announced a definitive agreement on Monday to acquire Gleamer SAS, a Paris-based pioneer in radiology artificial intelligence, for a total consideration of up to €230 million.
Yatsen Holding (NYSE:YSG) reported fourth-quarter and full-year 2025 results on Monday, marking a definitive turning point in its multi-year transition from a mass-market cosmetics player to a premium, skincare-led beauty group.
Global equity markets retreated sharply on Monday as a coordinated U.S. and Israeli military strike against Iran upended geopolitical stability, sending shockwaves through the travel and discretionary sectors.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade